SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Arrowhead Resarch
An SI Board Since October 2004
Posts SubjectMarks Bans Symbol
172 20 0 ARWR
Emcee:  mikehunt2 Type:  Moderated
Min  Hr  Day  Wk  Mon  Yr  3 Yr  Log
Introduction Market Data Compact
ARWR 42.39+0.2%Oct 31 9:30 AM EDT
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
172Arrowhead Stock Is Not Done Rallying After Its 38% Jump Chris Lau InvestorPlaceLynn-9/8/2018
171Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study Paul Lee-12/22/2017
170Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 StudPaul Lee-12/22/2017
169Arrowhead Reports Peak Reduction in HBsAg of Up to 99% (1.9 log) After a SinglePaul Lee-9/24/2015
168 Arrowhead Presents Data on Potential RNAi Candidate Targeting Factor 12 MediaPaul Lee-5/6/2015
167Arrowhead Research announced that it completed dosing volunteers and will beginPaul Lee-5/5/2015
166Paul do you want to moderate this board? It needs a logo and someone to take caSI Ron (Crazy Music Man)-5/4/2015
165Arrowhead Publishes SubQ Delivery Technology to Go Beyond the Liver [graphic]Paul Lee-5/4/2015
164 Arrowhead Begins Phase 1 Trial of ARC-AAT for Treatment of Liver Disease AssoPaul Lee-2/23/2015
163ARWR has been cur in half this morning: Arrowhead Research Sinks on DisappointiGlenn Petersen-10/8/2014
162While everyone is waiting to see if the HBV late-breaker abstract will show up nscaram(o)uche-10/3/2014
161Arrowhead Begins Dosing in Phase 2a Trial of RNAi Therapeutic ARC-520 in ChronicPaul Lee-3/24/2014
160Still time to get back in, it has a long time to runPaul Lee-3/15/2014
159Congratulations to all the longs. I sold a few years to early.zx-3/14/2014
158Arrowhead is on a tear today: Arrowhead Research: ‘Early Innings’ for ‘Major StGlenn Petersen13/5/2014
157I own shares in ARWR. Luke Timmerman is a good reporter. It probably helped thgcrispin-12/21/2013
156xconomy.com Arrowhead Picks Up Where Roche Left Off, Jumps Ahead in RNAi Paul Lee-12/20/2013
155Arrowhead Presents Data Suggesting ARC-520 Induces Therapeutic Flare in Chronic Paul Lee-11/4/2013
154 Arrowhead and Shire Enter into Collaboration and License Agreement to DevelPaul Lee-12/18/2012
153Arrowhead Presents Data Showing 99% Target Knockdown in Monkeys Without ToxicitPaul Lee-10/29/2012
152 Arrowhead Announces Dosing of First Patient with Anti-Obesity Treatment AdipPaul Lee-7/11/2012
151And the silence is deafening. ARWR continues to get funding and makes progress,lindalib-6/6/2012
150Arrowhead Research advances ARC-520 into IND-enabling studies for the treatment Paul Lee-6/6/2012
149 Arrowhead Research Corporation Acquires Alvos Therapeutics and Proprietary LiPaul Lee-4/11/2012
148 ArrowHead Research issued patent covering siRNA Inhibitors of HIF-2a Paul Lee-2/29/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News